Comment
. 2002 Dec;360(9350):2087-8; author reply 2088.
doi: 10.1016/s0140-6736(02)11986-6.
ICON3 and chemotherapy for ovarian cancer
- PMID: 12504454
- DOI: 10.1016/s0140-6736(02)11986-6
Item in Clipboard
Comment
ICON3 and chemotherapy for ovarian cancer
Lancet.
2002 Dec.
No abstract available
Comment on
-
Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: the ICON3 randomised trial.Lancet. 2002 Aug 17;360(9332):505-15. doi: 10.1016/S0140-6736(02)09738-6. Lancet. 2002. PMID: 12241653 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
